|

Emergency Resuscitative Endovascular Balloon Occlusion of the Aorta in Out of Hospital Cardiac Arrest

RECRUITINGN/ASponsored by Queen Mary University of London
Actively Recruiting
PhaseN/A
SponsorQueen Mary University of London
Started2024-06-04
Est. completion2026-06-01
Eligibility
Age18 Years – 80 Years
Healthy vol.Accepted

Summary

This study will assess the feasibility of performing pre-hospital resuscitative endovascular balloon occlusion of the aorta (REBOA) as an adjunct to conventional Advanced Life Support (ALS) in patients suffering from non-traumatic out of hospital cardiac arrest (OHCA). As well as providing valuable insights into the technical feasibility of performing this procedure as part of a resuscitation attempt, the study will also document the beneficial physiological effects of REBOA in this group of patients.

Eligibility

Age: 18 Years – 80 YearsHealthy volunteers accepted
Inclusion criteria

* Non-Traumatic OHCA in patients within the East of England area AND with a East Anglian Air Ambulance (EAAA) REBOA team in attendance
* Patients below or equal to 80yrs of age and above or equal to 18yrs of age, according to available information/estimate at scene
* No flow \<10 mins from data available (i.e. total period in OHCA with no CPR)
* In cardiac arrest (with no sustained ROSC) on arrival of the EAAA REBOA team

Exclusion criteria

* Patients aged less than 18 or above 80 years
* Known terminal illness
* Multiple severe co-morbidities
* Traumatic Cardiac Arrest (TCA)
* Inability to deploy mechanical CPR (e.g. LUCAS Device)
* Pregnancy, obvious or suspected

Conditions7

Cardiac ArrestCardiac ArrhythmiaHeart DiseaseOut-Of-Hospital Cardiac ArrestPulseless Electrical ActivityVentricular ArrythmiaVentricular Fibrillation

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.